Massimo Broggini

Medicine & Life Sciences

1. Ovarian Neoplasms 100%
2. Neoplasms 79%
3. Antineoplastic Agents 68%
4. Cell Line 56%
5. DNA 54%
6. Platinum 45%
7. Non-Small Cell Lung Carcinoma 45%
8. Pharmaceutical Preparations 44%
9. tallimustine 44%
10. brostallicin 42%
11. Doxorubicin 40%
12. stallimycin 38%
13. DNA Damage 36%
14. DNA Repair 35%
15. Genes 34%
16. Cisplatin 32%
17. pentamethylmelamine 30%
18. Growth 29%
19. Lewis Lung Carcinoma 26%
20. Heterografts 26%
21. In Vitro Techniques 25%
22. Mutation 24%
23. Altretamine 23%
24. Paclitaxel 22%
25. Clone Cells 22%
26. Apoptosis 22%
27. Proteins 21%
28. Drug Therapy 20%
29. Breast Neoplasms 19%
30. Carcinoma 18%
31. Phosphatidylinositol 3-Kinases 17%
32. Phosphatidylinositol 3-Kinase 17%
33. Gene Expression 17%
34. inositol-1,3,4,5,6-pentakisphosphate 16%
35. Therapeutics 16%
36. Daunorubicin 16%
37. PNU 151807 15%
38. Alkylation 15%
39. plitidepsin 15%
40. ARQ 197 15%
41. Glutathione Transferase 15%
42. Ovarian Epithelial Carcinoma 15%
43. Liver 15%
44. Neoplasm Metastasis 15%
45. Microsatellite Instability 14%
46. Phosphotransferases 14%
47. Cell Cycle 13%
48. Alkylating Agents 13%
49. Down-Regulation 13%
50. Survival 12%